Thanks Ahmed - Very helpful!
Hope you are well and my best wishes for the new year
Regards
Berenice
___________________________________________
Dr Berenice Lopez
Consultant Chemical Pathologist (Metabolic Medicine)
NNUH
-----Original Message-----
From: ACB AKI-Detection-Algorithm [mailto:[log in to unmask]] On Behalf Of Waise, Ahmed
Sent: 07 January 2015 09:07
To: [log in to unmask]
Subject: Re: Reporting Null results for the AKI warning stage test
Hi,
-Both AKI and eGFR/ CKD appear on reports.
-There is a comment on the FAQ list on the intranet syaing ' Patients with CKD may present with worsening kidney function that the program could flag as AKI due to the rising serum creatinine. For the time being both results/comments may appear in the patient record'
- Not sure if this answers your question but there about 1500 beds and currently there are around 60 'new' AKI per day. At less busier times there are around 40 per day.
bw
A
Ahmed Waise
Clinical Biochemistry
Poole and Bournemouth
________________________________________
From: ACB AKI-Detection-Algorithm [[log in to unmask]] on behalf of LOPEZ BERENICE (RM1) Norfolk and Norwich University Hospital [[log in to unmask]]
Sent: 05 January 2015 18:47
To: [log in to unmask]
Subject: Re: Reporting Null results for the AKI warning stage test
Dear all
Please may I pick your collective brains regarding:
- whether you are reporting e.GFR values on SCr results on in-patients
- how you are dealing with any automated e.GFR/CKD comments that may be released with the e.GFR value e.g. suppressing the comment when there is an AKI alert generated, modifying the comment etc.
- numbers of new AKI alerts (1-3) generated in acute trusts (I have some data on this but not clear how many new alerts we should expect to generate in a (1)500 (2) 1000 bed hospital
Many thanks
Dr Berenice Lopez
Consultant Chemical Pathologist (Metabolic Medicine)
-----Original Message-----
From: ACB AKI-Detection-Algorithm [mailto:[log in to unmask]] On Behalf Of Hill Robert (NORTH BRISTOL NHS TRUST)
Sent: 23 December 2014 18:20
To: [log in to unmask]
Subject: Reporting Null results for the AKI warning stage test
---
This message was sent from an email address external to NHSmail but gives the appearance of being from an NHSmail (@nhs.net) address. The recipient should verify the sender and content before acting upon information contained within.
The identified sender is [log in to unmask]
---
We are aware that some laboratories are reporting null results ("0") for the AKI warning stage result without an interpretive comment This is potentially dangerous and is poor practice. The best practice document (link below) suggests that, ideally, null results should not be reported.
If this is not possible, a clear interpretive comment, preferably agreed with service users, should accompany the report containing a null result.
https://www.thinkkidneys.nhs.uk/wp-content/uploads/2014/12/AKI-Warning-Algorithm-Best-Practice-Guidance-final-publication-0112141.pdf
Dr Robert Hill
Consultant Clinical Biochemist
********************************************************************************************************************
This message may contain confidential information. If you are not the intended recipient please inform the sender that you have received the message in error before deleting it.
Please do not disclose, copy or distribute information in this e-mail or take any action in reliance on its contents:
to do so is strictly prohibited and may be unlawful.
Thank you for your co-operation.
NHSmail is the secure email and directory service available for all NHS staff in England and Scotland NHSmail is approved for exchanging patient data and other sensitive information with NHSmail and GSi recipients NHSmail provides an email address for your career in the NHS and can be accessed anywhere
********************************************************************************************************************
This email and any files transmitted with it are confidential and intended solely for the use of the individual or entity to whom they are addressed.
If you have received this email in error please notify the originator of the message. This footer also confirms that this email message has been scanned for the presence of computer viruses but this should not be relied upon as a guarantee that the contents are virus free.
Any views expressed in this message are those of the individual sender, except where the sender specifies and with authority, states them to be the views of the Norfolk and Norwich University Hospitals NHS Foundation Trust. The information contained in this e-mail may be subject to public disclosure under the Freedom of Information Act 2000. Unless the information is legally exempt from disclosure, the confidentiality of this e-mail and your reply cannot be guaranteed
DISCLAIMER: This email and any files transmitted with it are confidential and intended solely for the use of the individual, individuals or entity to whom they are addressed. Any views or opinions expressed are those of the author and do not necessarily represent the views of Poole Hospital NHS Foundation Trust unless otherwise explicitly stated. This email may contain confidential and/or privileged materials. In the case of confidential and/or privileged materials, any review, retransmission, dissemination or other use of these materials by individuals or entities other than the intended recipient may be the subject of legal action. If you receive an email in error from Poole Hospital NHS Foundation Trust, please contact the sender and delete the material from your computer.
This email and any files transmitted with it are confidential and intended solely for the use of the individual or entity to whom
they are addressed.
If you have received this email in error please notify the originator of the message. This footer also confirms that this
email message has been scanned for the presence of computer viruses but this should not be relied upon as a guarantee that the contents are virus free.
Any views expressed in this message are those of the individual sender, except where the sender specifies and with authority,
states them to be the views of the Norfolk and Norwich University Hospitals NHS Foundation Trust. The information contained in this e-mail may be subject to public disclosure
under the Freedom of Information Act 2000. Unless the information is legally exempt from disclosure, the confidentiality of this e-mail and your reply cannot be guaranteed
|